250 related articles for article (PubMed ID: 17564346)
1. [Myasthenia gravis: treatments and remissions].
Dunand M; Lalive PH; Vokatch N; Kuntzer T
Rev Med Suisse; 2007 May; 3(110):1185-6, 1188-90. PubMed ID: 17564346
[TBL] [Abstract][Full Text] [Related]
2. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
3. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
Bau V; Hanisch F; Hain B; Zierz S
Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation and management of myasthenia gravis.
Keesey JC
Muscle Nerve; 2004 Apr; 29(4):484-505. PubMed ID: 15052614
[TBL] [Abstract][Full Text] [Related]
5. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
[TBL] [Abstract][Full Text] [Related]
6. Pearls: myasthenia.
Benatar M
Semin Neurol; 2010 Feb; 30(1):35-7. PubMed ID: 20127579
[TBL] [Abstract][Full Text] [Related]
7. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
8. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
[TBL] [Abstract][Full Text] [Related]
9. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
[TBL] [Abstract][Full Text] [Related]
10. [Methods for diagnosing seronegative myasthenia gravis].
Blanco-Hernández T; Navarré-Gimeno A; Brocalero-Camacho A; Cervelló-Donderis A; López-Trigo J; Ortiz-Sánchez P; Sancho-Rieger J
Rev Neurol; 2008 Mar 16-31; 46(6):360-4. PubMed ID: 18368681
[TBL] [Abstract][Full Text] [Related]
11. [Recent advancement in the basic and clinical studies in myasthenia gravis].
Okumura M; Shiono H
Kyobu Geka; 2011 Jan; 64(1):79-89. PubMed ID: 21229683
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
[TBL] [Abstract][Full Text] [Related]
14. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
Wolfe GI; Oh SJ
Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
[TBL] [Abstract][Full Text] [Related]
15. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
Maruyama N; Shigemoto K
Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
[TBL] [Abstract][Full Text] [Related]
17. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
[TBL] [Abstract][Full Text] [Related]
18. [Myasthenia gravis: diagnosis and treatment].
Suárez GA
Rev Neurol; 1999 Jul 16-31; 29(2):162-5. PubMed ID: 10528332
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibitors in MG: to be or not to be?
Punga AR; Stålberg E
Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048
[TBL] [Abstract][Full Text] [Related]
20. [Juvenile myasthenia gravis].
Papazian O; Alfonso I
Medicina (B Aires); 2009; 69(1 Pt 1):71-83. PubMed ID: 19240004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
